Your browser doesn't support javascript.
loading
Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab.
Cousin, S; Toulmonde, M; Kind, M; Cazeau, A-L; Bechade, D; Coindre, J-M; Italiano, A.
Affiliation
  • Cousin S; Early Phase Trials Unit; Department of Medicine.
  • Toulmonde M; Early Phase Trials Unit; Department of Medicine.
  • Kind M; Department of Radiology.
  • Cazeau AL; Department of Nuclear Medicine.
  • Bechade D; Department of Medicine.
  • Coindre JM; Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Italiano A; Early Phase Trials Unit; Department of Medicine. Electronic address: a.italiano@bordeaux.unicancer.fr.
Ann Oncol ; 27(6): 1178-1179, 2016 06.
Article in En | MEDLINE | ID: mdl-27091806
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis, Pulmonary / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological Limits: Female / Humans / Middle aged Language: En Journal: Ann Oncol Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis, Pulmonary / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological Limits: Female / Humans / Middle aged Language: En Journal: Ann Oncol Year: 2016 Document type: Article